CIK 0001649989
- Non-accelerated filer
- Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383982704
- Phone
- +1 609-619-3990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-05-18 | Brady Todd C Director | Conversion | +66,333 | 124,303 | ||
| 2016-05-18 | Brady Todd C Director | Conversion · Series A Preferred Stock | −398 | 0 | ||
| 2016-05-13 | Bahrt Kenneth Chief Medical Officer | Purchase | +2,000 | 2,000 | ||
| 2016-05-13 | Bahrt Kenneth Chief Medical Officer | Purchase · Series A Warrants (right to buy) | +1,000 | 1,000 | ||
| 2016-05-13 | Bahrt Kenneth Chief Medical Officer | Purchase · Series B Warrants (right to buy) | +1,000 | 1,000 | ||
| 2016-05-11 | Mohan Pankaj President & CEO | Conversion | +17,666 | 39,405 |
Page 20 of 20 · 386 trades